Raymond James Financial »

Kymera Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $16M 136k 114.67
2025-06-30 $73k 1.7k 43.64

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p Mcp Etf (IJH)
Wal-Mart Stores (WMT)

View all positions for Raymond James Financial

Top funds holding Kymera Therapeutics

FMR
Baker Bros. Advisors
venBio Select Advisor
T. Rowe Price Associates
BlackRock
BVF
Wellington Management Company
Vanguard Portfolio Management
Siren
Vanguard Capital Management
Atlas Venture Life Science Advisors
State Street Corporation
Geode Capital Management
Capital Research Global Investors
Goldman Sachs Group

View all funds holding Kymera Therapeutics